Publications: Prof William Drake
Grant B, Ratnayake G, Williams CL, Long A, Halsall DJ, Semple RK, Cavenagh JD, Drake WM et al.
(
2023
)
.
Resolution of dysglycaemia after treatment of monoclonal gammopathy of endocrine significance
.
European Journal of Endocrinology
vol.
189
,
(
6
)
k25
-
k29
.
Goodchild E, Senanayake R, Wu X, Bashari W, Salsbury J, Argentesi G, O'Toole SM, McFarlane J et al.
(
2023
)
.
FRI156 Novel Radiolabeled Ligand, Para-chloro-2-[18F]fluoroethyletomidate (CETO) Is Equivalent To [11C]metomidate-PET (MTO) For The Lateralisation Of Primary Aldosteronism (PA)
.
Journal of the Endocrine Society
vol.
7
,
(
Supplement_1
)
Argentesi G, Wu X, Ney A, Goodchild E, Laycock K, Lee Y-N, Senanayake R, MacFarlane J et al.
(
2023
)
.
THU594 Outcome Data From Fabulas: A Feasibility Study Of Radiofrequency Endoscopic Ablation, With Ultrasound Guidance, As A Non-surgical, Adrenal Sparing Treatment For Aldosterone Producing Adenomas
.
Journal of the Endocrine Society
vol.
7
,
(
Supplement_1
)
Azizan EAB, Drake WM, Brown MJ
(
2023
)
.
Primary aldosteronism: molecular medicine meets public health
.
Nature Reviews Nephrology
vol.
19
,
(
12
)
788
-
806
.
Lee Y-N, Drake WM
(
2023
)
.
Radiofrequency Ablation in Primary Aldosteronism
.
Experimental and Clinical Endocrinology & Diabetes
vol.
131
,
(
07/08
)
438
-
442
.
Hamblin R, Fountas A, Lithgow K, Loughrey PB, Bonanos E, Shinwari SK, Mitchell K, Shah S et al.
(
2023
)
.
Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium
.
European Journal of Endocrinology
vol.
189
,
(
1
)
87
-
95
.
Wu X, Azizan EAB, Goodchild E, Garg S, Hagiyama M, Cabrera CP, Fernandes-Rosa FL, Boulkroun S et al.
(
2023
)
.
Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production
.
Nature Genetics
vol.
55
,
(
6
)
1009
-
1021
.
Kaniuka-Jakubowska S, Levy MJ, Pal A, Abeyaratne D, Drake WM, Kyriakakis N, Murray RD, Orme SM et al.
(
2023
)
.
A study of acromegaly-associated headache with somatostatin analgesia
.
Endocrine Related Cancer
vol.
30
,
(
3
)
Wu X, Senanayake R, Goodchild E, Bashari WA, Salsbury J, Cabrera CP, Argentesi G, O’Toole SM et al.
(
2023
)
.
[11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial
.
Nature Medicine
vol.
29
,
(
1
)
190
-
202
.
Koh CH, Khan DZ, Digpal R, Horsfall HL, Ali AMS, Baldeweg SE, Bouloux P-M, Dorward NL et al.
(
2023
)
.
The clinical outcomes of imaging modalities for surgical management Cushing’s disease – A systematic review and meta-analysis
.
Frontiers in Endocrinology
vol.
13
,
Tufton N, Hearnden RJ, Berney DM, Drake WM, Parvanta L, Chapple JP, Akker SA
(
2022
)
.
The immune cell infiltrate in the tumour microenvironment of phaeochromocytomas and paragangliomas
.
Endocrine Related Cancer
vol.
29
,
(
11
)
589
-
598
.
Perros P, Basu A, Boelaert K, Dayan C, Vaidya B, Williams GR, Lazarus JH, Hickey J et al.
(
2022
)
.
Postradioiodine Graves' management: The PRAGMA study
.
Clinical Endocrinology
vol.
97
,
(
5
)
664
-
675
.
Zhou J, Azizan EAB, Cabrera CP, Fernandes-Rosa FL, Boulkroun S, Argentesi G, Cottrell E, Amar L et al.
(
2021
)
.
Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause
.
Nature Genetics
O’Toole SM, Hornby C, Sze WC, Hannon MJ, Akker SA, Druce MR, Waterhouse M, Dawnay A et al.
(
2021
)
.
Performance evaluation of scoring systems for predicting post‐operative hypertension cure in primary aldosteronism
.
Clinical Endocrinology
vol.
95
,
(
4
)
576
-
586
.
Stiles CE, Lloyd G, Bhattacharyya S, Steeds RP, Boomla K, Bestwick JP, Drake WM
(
2020
)
.
Incidence of Cabergoline-Associated Valvulopathy in Primary Care Patients With Prolactinoma Using Hard Cardiac Endpoints
.
The Journal of Clinical Endocrinology & Metabolism
vol.
106
,
(
2
)
e711
-
e720
.
Ohno Y, Naruse M, Beuschlein F, Schreiner F, Parasiliti-Caprino M, Deinum J, Drake WM, Fallo F et al.
(
2020
)
.
Adrenal Venous Sampling–Guided Adrenalectomy Rates in Primary Aldosteronism: Results of an International Cohort (AVSTAT)
.
The Journal of Clinical Endocrinology & Metabolism
vol.
106
,
(
3
)
1400
-
1407
.
Marques P, Magalhães D, Caimari F, Hernández RL, Collier D, Lim C, Stals K, Ellard S et al.
(
2020
)
.
Phenotypic differences between patients with familial pituitary neuroendocrine tumours due to MEN1 or AIP mutations
.
Endocrine Abstracts
O’Toole SM, Sze W-CC, Chung T-T, Akker SA, Druce MR, Waterhouse M, Pitkin S, Dawnay A et al.
(
2020
)
.
Low-grade Cortisol Cosecretion Has Limited Impact on ACTH-stimulated AVS Parameters in Primary Aldosteronism
.
The Journal of Clinical Endocrinology & Metabolism
vol.
105
,
(
10
)
LeCain M, Fraterrigo G, Drake WM
(
2020
)
.
Induced Lactation in a Mother Through Surrogacy With Complete Androgen Insensitivity Syndrome (CAIS)
.
Journal of Human Lactation
vol.
36
,
(
4
)
791
-
794
.
Pittaway JFH, Harrison C, Rhee Y, Holder-Espinasse M, Fryer AE, Cundy T, Drake WM, Irving MD
(
2019
)
.
Correction to: Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome – new data and literature review
.
vol.
14
,
is.
1
,
Springer Nature
Chowdhury TA, Khan H, Druce MR, Drake WM, Rajakariar R, Thuraisingham R, Dobbie H, Parvanta L et al.
(
2019
)
.
Flipped learning: Turning medical education upside down
.
Future Healthcare Journal
vol.
6
,
(
3
)
192
-
195
.
Hadjidemetriou I, Mariniello K, Ruiz-Babot G, Pittaway J, Mancini A, Mariannis D, Gomez-Sanchez CE, Parvanta L et al.
(
2019
)
.
DLK1/PREF1 marks a novel cell population in the human adrenal cortex
.
The Journal of Steroid Biochemistry and Molecular Biology
vol.
193
,
Jacob P, Dow C, Lasker SS, Drake WM, Chowdhury TA
(
2019
)
.
Hyponatraemia in primary care
.
The BMJ
vol.
365
,
Tufton N, White G, Drake WM, Sahdev A, Akker SA
(
2019
)
.
Diffusion‐weighted imaging (DWI) highlights SDHB‐related tumours: A pilot study
.
Clinical Endocrinology
vol.
91
,
(
1
)
104
-
109
.
Lim ES, Shah SG, Waterhouse M, Akker S, Drake W, Plowman N, Berney DM, Richards P et al.
(
2019
)
.
Impact of thyroiditis on 131I uptake during ablative therapy for differentiated thyroid cancer
.
Endocrine Connections
vol.
8
,
(
5
)
454
-
461
.
Steeds R, Stiles C, Sharma V, Chambers J, Lloyd G, Drake W
(
2019
)
.
Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: A joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology
.
Clinical Endocrinology
vol.
90
,
(
5
)
662
-
669
.
CHAPPLE JP, O'TOOLE S, WATSON D, NOVOSELOVA T, ROMANO L, KING PJ, BRADSHAW T, THOMPSON CL et al.
(
2019
)
.
Oncometabolite induced primary cilia loss in pheochromocytoma
.
Endocrine-Related Cancer
Tshuma N, Glynn N, Evanson J, Powles T, Drake WM
(
2018
)
.
Hypothalamitis and severe hypothalamic dysfunction associated with anti–programmed cell death ligand 1 antibody treatment
.
European Journal of Cancer
vol.
104
,
247
-
249
.
Wilkinson IC, Riddoch F, Perry LA, Martin L, Grossman AB, Monson JP, Akker S, Savage MO et al.
.
New insights into the low dose dexamethasone suppression test in paediatric Cushing's syndrome (CS)
.
Endocrine Abstracts
.
O'Toole SM, Sahdev A, Bhattacharya S, Feakins R, Gevers EF, Drake WM
(
2018
)
.
Paediatric pancreatic neuroendocrine tumours in von Hippel–Lindau disease
.
Endocrine Related Cancer
vol.
25
,
(
9
)
l43
-
l47
.
Pittaway JFH, Harrison C, Rhee Y, Holder-Espinasse M, Fryer AE, Cundy T, Drake WM, Irving MD
(
2018
)
.
Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome – new data and literature review
.
Orphanet Journal of Rare Diseases
vol.
13
,
(
1
)
Ruiz-Babot G, Balyura M, Hadjidemetriou I, Ajodha SJ, Taylor DR, Ghataore L, Taylor NF, Schubert U et al.
(
2018
)
.
Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells
.
Cell Reports
vol.
22
,
(
5
)
1236
-
1249
.
O'Toole SM, Drake WM
(
2017
)
.
Response to Somatostatin Analog Therapy in a Patient With von Hippel-Lindau Disease and Multiple Pancreatic Neuroendocrine Tumors
.
Pancreas
vol.
46
,
(
7
)
Hussain S, Hallam S, Beltran L, Haroon A, Majumdar K, Shamash J, Sivapackianathan R, Drake W
(
2017
)
.
Intravascular large B‐cell lymphoma presenting as a pituitary mass with bilateral adrenal enlargement and haemophagocytic lymphohistiocytosis
.
British Journal of Haematology
vol.
181
,
(
6
)
851
-
852
.
Tufton N, Gunganah K, Hussain S, Druce M, Carpenter R, Ashby M, Drake WM, Akker SA
(
2017
)
.
Alpha blockade—not to be underdone
.
vol.
86
,
is.
2
,
pp.
306
-
308
.
Wiley
Srirangalingam U, LeCain M, Tufton N, Akker SA, Drake WM, Metcalfe K
(
2016
)
.
Four generations of SDHB-related disease: complexities in management
.
Familial Cancer
vol.
16
,
(
2
)
279
-
282
.
Tufton N, Shapiro L, Srirangalingam U, Richards P, Sahdev A, Kumar AV, McAndrew L, Martin L et al.
(
2016
)
.
Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers
.
Clinical Endocrinology
vol.
86
,
(
2
)
286
-
296
.
Baldeweg SE, Vanderpump M, Drake W, Reddy N, Markey A, Plant GT, Powell M, Sinha S et al.
(
2016
)
.
SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of pituitary apoplexy in adult patients
.
Endocrine Connections
vol.
5
,
(
5
)
g12
-
g15
.
Brown MJ, Drake WM
(
2016
)
.
Splitting atoms: the Endocrine Society guideline for the management of primary aldosteronism
.
The Lancet Diabetes & Endocrinology
vol.
4
,
(
10
)
805
-
807
.
Srirangalingam U, Banerjee A, Patki P, Peters J, George E, Chew SL, Kumar VKA, Korbonits M et al.
(
2016
)
.
Succinate Dehydrogenase B (SDHB)-Associated Bladder Paragangliomas
.
Clinical Genitourinary Cancer
vol.
15
,
(
1
)
e131
-
e136
.
Shapiro L, Elahi S, Riddoch F, Perry LA, Martin L, Akker SA, Monson JP, Drake WM et al.
(
2016
)
.
Investigation for Paediatric Cushing's Syndrome Using Twenty-Four-Hour Urinary Free Cortisol Determination
.
Horm Res Paediatr
vol.
86
,
(
1
)
21
-
26
.
Chung TT, Gunganah K, Monson JP, Drake WM
(
2016
)
.
Circadian variation in serum cortisol during hydrocortisone replacement is not attributable to changes in cortisol‐binding globulin concentrations
.
Clinical Endocrinology
vol.
84
,
(
4
)
496
-
500
.
Gunganah K, Carpenter R, Drake WM
(
2015
)
.
Eplerenone use in primary aldosteronism during pregnancy
.
Clinical Case Reports
vol.
4
,
(
1
)
81
-
82
.
Mownah OA, Pafitanis G, Drake WM, Crinnion JN
(
2015
)
.
Contemporary surgical treatment of primary hyperparathyroidism without intraoperative parathyroid hormone measurement
.
Annals of The Royal College of Surgeons of England
vol.
97
,
(
8
)
603
-
607
.
Sze WCC, McQuillan J, Plowman PN, MacDougall N, Blackburn P, Sabin HI, Ali N, Drake WM
(
2015
)
.
Stereotactic radiosurgery XX: ocular neuromyotonia in association with gamma knife radiosurgery
.
Endocrinology Diabetes and Metabolism Case Reports
vol.
2015
,
(
1
)
Hussain S, Panteliou E, Berney DM, Carpenter R, Matson M, Sahdev A, Bell M, O'Sullivan E et al.
(
2015
)
.
Pure aldosterone-secreting adrenocortical carcinoma in a patient with refractory primary hyperaldosteronism
.
Endocrinology Diabetes and Metabolism Case Reports
vol.
2015
,
(
1
)
Corrigall D, Ziolkowski B, Woodland P, Hannon M, ChinAleong J, Jenkins P, Fairclough P, Drake W et al.
(
2015
)
.
PWE-351 Acromegaly and colonic polyps revisited: time to change the guidelines?
.
Gut
.
vol.
64
,
Dénes J, Swords F, Rattenberry E, Stals K, Owens M, Cranston T, Xekouki P, Moran L et al.
(
2014
)
.
Heterogeneous Genetic Background of the Association of Pheochromocytoma/Paraganglioma and Pituitary Adenoma: Results From a Large Patient Cohort
.
The Journal of Clinical Endocrinology & Metabolism
vol.
100
,
(
3
)
e531
-
e541
.
Sivapackianathan R, Parker A, Carpenter R, Achan P, Rastogi A, Sarkodieh J, Drake WM
(
2014
)
.
Profound vitamin D deficiency in coeliac disease and pregnancy
.
QJM
vol.
108
,
(
4
)
345
-
346
.
Nadarasa K, Theodoraki A, Kurzawinski TR, Carpenter R, Bull J, Chung TT, Drake WM
(
2014
)
.
Denosumab for management of refractory hypercalcaemia in recurrent parathyroid carcinoma
.
European Journal of Endocrinology
vol.
171
,
(
3
)
l7
-
l8
.
Gupta PS, Grozinsky-Glasberg S, Drake WM, Akker SA, Perry L, Grossman AB, Druce MR
(
2014
)
.
Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
.
Clinical Endocrinology
vol.
80
,
(
2
)
246
-
252
.
Drake WM, Stiles CE, Howlett TA, Toogood AA, Bevan JS, Steeds RP, Group OBOTUDAV
(
2013
)
.
A Cross-Sectional Study of the Prevalence of Cardiac Valvular Abnormalities in Hyperprolactinemic Patients Treated With Ergot-Derived Dopamine Agonists
.
The Journal of Clinical Endocrinology & Metabolism
vol.
99
,
(
1
)
90
-
96
.
Cavlan D, Vijayaraghavan S, Gelding S, Drake W
(
2013
)
.
GH replacement causing acute hyperglycaemia and ketonuria in a type 1 diabetic patient
.
Endocrinology Diabetes and Metabolism Case Reports
vol.
2013
,
(
1
)
Sze WCC, Grossman AB, Goddard I, Amendra D, Shieh SCC, Plowman PN, Drake WM, Akker SA et al.
(
2013
)
.
Sequelae and survivorship in patients treated with 131I-MIBG therapy
.
British Journal of Cancer
vol.
109
,
(
3
)
565
-
572
.
Alexandraki KI, Kaltsas GA, Isidori AM, Storr HL, Afshar F, Sabin I, Akker SA, Chew SL et al.
(
2013
)
.
Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study
.
European Journal of Endocrinology
vol.
168
,
(
4
)
639
-
648
.
Khan K, Drake, Akker S, White V
(
2012
)
.
P50 Pituitary Granulomata - TB or Not TB
.
Thorax
.
vol.
67
,
Sehgal V, Vijayan S, Yasmin S, Srirangalingam U, Pati J, Drake
(
2011
)
.
Normocalcaemic tetany
.
Clinical Medicine
vol.
11
,
(
6
)
594
-
595
.
Bharwani N, Rockall AG, Sahdev A, Gueorguiev M, Drake W, Grossman AB, Reznek RH
(
2011
)
.
Adrenocortical carcinoma: the range of appearances on CT and MRI
.
American Journal of Roentgenology
vol.
196
,
(
6
)
w706
-
w714
.
Simpson MA, Irving MD, Asilmaz E, Gray MJ, Dafou D, Elmslie FV, Mansour S, Holder SE et al.
(
2011
)
.
Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss
.
Nature Genetics
vol.
43
,
(
4
)
303
-
305
.
Druce MR, Walker D, Maher KT, Dodzo K, Perry L, Ball S, Peaston R, Chew SL et al.
(
2011
)
.
The Effect of Exogenous Glucocorticoids on Plasma Catecholamines and Metanephrines in Patients Without Phaeochromocytomas
.
Hormone and Metabolic Research
vol.
43
,
(
04
)
292
-
295
.
Rajasekaran S, Vanderpump M, Baldeweg S, Drake W, Reddy N, Lanyon M, Markey A, Plant G et al.
(
2010
)
.
UK guidelines for the management of pituitary apoplexy
.
Clinical Endocrinology
vol.
74
,
(
1
)
9
-
20
.
Salehi F, Scheithauer BW, Moyes VJ, Drake WM, Syro LV, Manoranjan B, Sharma S, Horvath E et al.
(
2010
)
.
Low Immunohistochemical Expression of MGMT in ACTH Secreting Pituitary Tumors of Patients with Nelson Syndrome
.
Endocrine Pathology
vol.
21
,
(
4
)
227
-
229
.
Chung TTLL, Drake WM, Plowman PN, Metcalfe K, Grossman AB, Akker SA, Chew SL, Besser GM et al.
(
2010
)
.
No clear evidence for an association between GH replacement and relapse of intracranial germ cell tumours: single centre and KIMS experience
.
European Journal of Endocrinology
vol.
163
,
(
2
)
357
-
358
.
Misra S, Johnston LB, Drake WM
(
2010
)
.
Severe hypernatraemia associated with growth hormone replacement therapy in a patient with septo-optic dysplasia
.
Pituitary
vol.
13
,
(
2
)
186
-
188
.
Igreja S, Chahal HS, King P, Bolger GB, Srirangalingam U, Guasti L, Chapple JP, Trivellin G et al.
(
2010
)
.
Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families
.
Human Mutation
vol.
31
,
(
8
)
950
-
960
.
Dworakowska D, Gueorguiev M, Kelly P, Monson JP, Besser GM, Chew SL, Akker SA, Drake WM et al.
(
2010
)
.
Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines
.
European Journal of Endocrinology
vol.
163
,
(
1
)
21
-
28
.
Barwick T, Murray I, Megadmi H, Drake WM, Plowman PN, Akker SA, Chew SL, Grossman AB et al.
(
2010
)
.
Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT
.
European Journal of Endocrinology
vol.
162
,
(
6
)
1131
-
1139
.
Ananth S, Cheng L, Anderson J, Drake W, Rowe S, Burke S, Richards P, Offiah C et al.
(
2009
)
.
Parathyroid surgery—a local survey
.
British Journal of Oral and Maxillofacial Surgery
vol.
47
,
(
7
)
Procopiou M, Finney H, Akker SA, Chew SL, Drake WM, Burrin J, Grossman AB
(
2009
)
.
Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors
.
European Journal of Endocrinology
vol.
161
,
(
3
)
509
-
509
.
Higham CE, Chung TT, Lawrance J, Drake WM, Trainer PJ
(
2009
)
.
Long‐term experience of pegvisomant therapy as a treatment for acromegaly
.
Clinical Endocrinology
vol.
71
,
(
1
)
86
-
91
.
Higham CE, Thomas JDJ, Bidlingmaier M, Drake WM, Trainer PJ
(
2009
)
.
Successful use of weekly pegvisomant administration in patients with acromegaly
.
European Journal of Endocrinology
vol.
161
,
(
1
)
21
-
25
.
Procopiou M, Finney H, Akker SA, Chew SL, Drake WM, Burrin J, Grossman AB
(
2009
)
.
Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors
.
European Journal of Endocrinology
vol.
161
,
(
1
)
131
-
140
.
Alexandraki KI, Kaltsas GA, Isidori AM, Akker SA, Drake WM, Chew SL, Monson JP, Besser GM et al.
(
2009
)
.
The prevalence and characteristic features of cyclicity and variability in Cushing's disease
.
European Journal of Endocrinology
vol.
160
,
(
6
)
1011
-
1018
.
Srirangalingam U, Khoo B, Walker L, MacDonald F, Skelly RH, George E, Spooner D, Johnston LB et al.
(
2009
)
.
Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours
.
Endocrine Related Cancer
vol.
16
,
(
2
)
515
-
525
.
Moyes VJ, Alusi G, Sabin HI, Evanson J, Berney DM, Kovacs K, Monson JP, Plowman PN et al.
(
2008
)
.
Treatment of Nelson's syndrome with temozolomide
.
European Journal of Endocrinology
vol.
160
,
(
1
)
115
-
119
.
Moyes VJ, Metcalfe KA, Drake WM
(
2008
)
.
Clinical use of cabergoline as primary and adjunctive treatment for acromegaly
.
EUR J ENDOCRINOL
vol.
159
,
(
5
)
541
-
545
.
Jimenez C, Burman P, Abs R, Clemmons DR, Drake WM, Hutson KR, Messig M, Thorner MO et al.
(
2008
)
.
Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials
.
European Journal of Endocrinology
vol.
159
,
(
5
)
517
-
523
.
Chung TT, Evanson J, Walker D, Akker SA, Besser GM, Monson JP, Grossman AB, Drake WM
(
2008
)
.
Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours
.
Clin Endocrinol (Oxf)
vol.
68
,
(
6
)
965
-
969
.
Colson A, Walker D, Besser GM, Grossman AB, Chew SL, Jenkins PJ, Drake WM, Monson JP
(
2008
)
.
Role of fasting plasma glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose intolerance in adult hypopituitary patients during growth hormone replacement therapy
.
HORM RES
vol.
69
,
(
2
)
83
-
88
.
Coyle FM, Taylor NF, Monson JP, Drake WM, Foster GR
(
2007
)
.
Non-alcoholic fatty liver disease is associated with transcriptional dysregulation of the corticosteroid metabolising enzyme II beta HSD-1 leading to excess intrahepatic steroid exposure
.
HEPATOLOGY
.
vol.
46
,
741A
-
741A
.
Brooke AM, Drake WM
(
2007
)
.
Serum IGF-I levels in the diagnosis and monitoring of acromegaly
.
PITUITARY
vol.
10
,
(
2
)
173
-
179
.
Peters CJ, Nugent T, Perry LA, Davies K, Morel Y, Drake WM, Savage MO, Johnston LB
(
2007
)
.
Cosegregation of a novel homozygous CYP11B1 mutation with the phenotype of non-classical congenital adrenal hyperplasia in a consanguineous family
.
HORM RES
vol.
67
,
(
4
)
189
-
193
.
Chahal HS, Drake WM
(
2007
)
.
The endocrine system and ageing
.
J PATHOL
vol.
211
,
(
2
)
173
-
180
.
Agha A, Walker D, Perry L, Drake WM, Chew SL, Jenkins PJ, Grossman AB, Monson JP
(
2007
)
.
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients
.
Clin Endocrinol (Oxf)
vol.
66
,
(
1
)
72
-
77
.
Ogilvie CM, Brown PL, Matson M, Dacie J, Reznek RH, Britton K, Carpenter R, Berney D et al.
(
2006
)
.
Selective parathyroid venous sampling in patients with complicated hyperparathyroidism
.
EUR J ENDOCRINOL
vol.
155
,
(
6
)
813
-
821
.
Paisley AN, O'Callaghan CJ, Lewandowski KC, Parkinson C, Roberts ME, Drake WM, Monson JP, Trainer PJ et al.
(
2006
)
.
Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegaly
.
J CLIN ENDOCR METAB
vol.
91
,
(
11
)
4635
-
4640
.
Ali N, Sebastian C, Foley RR, Murray I, Canizales AL, Jenkins PJ, Drake WM, Plowman PN et al.
(
2006
)
.
The management of differentiated thyroid cancer using I-123 for imaging to assess the need for I-131 therapy
.
NUCL MED COMMUN
vol.
27
,
(
2
)
165
-
169
.
Priesemann M, Davies KM, Perry LA, Drake WM, Chew SL, Monson JP, Savage MO, Johnston LB
(
2006
)
.
Benefits of screening in von Hippel-Lindau disease--comparison of morbidity associated with initial tumours in affected parents and children
.
Horm Res
vol.
66
,
(
1
)
1
-
5
.
Colson A, Brooke AM, Walker D, Besser GM, Chew SL, Grossman AB, Jenkins PJ, Drake WM et al.
(
2006
)
.
Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density
.
Horm Res
vol.
66
,
(
6
)
257
-
267
.
Barkan AL, Burman P, Clemmons DR, Drake WM, Gagel RF, Harris PE, Trainer PJ, van der Lely AJ et al.
(
2005
)
.
Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant
.
J CLIN ENDOCR METAB
vol.
90
,
(
10
)
5684
-
5691
.
Chung TT, Drake WM, Evanson J, Walker D, Plowman PN, Chew SL, Grossman AB, Besser GM et al.
(
2005
)
.
Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement
.
CLIN ENDOCRINOL
vol.
63
,
(
3
)
274
-
279
.
Drake WM, Berney DM, Kovacs K, Monson JP
(
2005
)
.
Markers of cell proliferation in a GH-producing adenoma of a patient treated with pegvisomant
.
EUR J ENDOCRINOL
vol.
153
,
(
2
)
203
-
205
.
Drake WM, Loureiro RA, Parkinson C, Monson JP, Besser GM, Trainer PJ
(
2005
)
.
Disease activity in acromegaly may be assessed 6 weeks after discontinuation of pegvisomant
.
Eur J Endocrinol
vol.
152
,
(
1
)
47
-
51
.
Drake WM, Grossman AB, Hutson RK
(
2005
)
.
Effect of treatment with pegvisomant on meningioma growth in vivo
.
EUR J ENDOCRINOL
vol.
152
,
(
1
)
161
-
162
.
Carroll PV, Drake WM, Maher KT, Metcalfe K, Shaw NJ, Dunger DB, Cheetham TD, Camacho-Hübner C et al.
(
2004
)
.
Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth
.
J Clin Endocrinol Metab
vol.
89
,
(
8
)
3890
-
3895
.
Savage MO, Drake WM, Carroll PV, Monson JP
(
2004
)
.
Transitional care of GH deficiency: when to stop GH therapy
.
EUR J ENDOCRINOL
vol.
151
,
S61
-
S65
.
Paisley AN, Trainer PJ, Drake WM
(
2004
)
.
The place of pegvisomant in the acromegaly treatment algorithm
.
GROWTH HORMONE & IGF RESEARCH
.
vol.
14
,
S101
-
S106
.
Drake WM, Kendler DL, Rosen CJ, Orwoll ES
(
2003
)
.
An investigation of the predictors of bone mineral density and response to therapy with alendronate in osteoporotic men
.
J Clin Endocrinol Metab
vol.
88
,
(
12
)
5759
-
5765
.
Drake WM, Rowles SV, Roberts ME, Fode FK, Besser GM, Monson JP, Trainer PJ
(
2003
)
.
Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomant
.
Eur J Endocrinol
vol.
149
,
(
6
)
521
-
527
.
Jenkins PJ, Satta MA, Simmgen M, Drake WM, Williamson C, Lowe DG, Britton K, Chew SL et al.
(
2003
)
.
Metastatic parathyroid carcinoma in the MEN2A syndrome
.
Clinical Endocrinology
vol.
47
,
(
6
)
747
-
751
.
Drake WM, Carroll PV, Maher KT, Metcalfe KA, Camacho-Hubner C, Shaw NJ, Dunger DB, Cheetham TD et al.
(
2003
)
.
The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth - Response
.
J CLIN ENDOCR METAB
vol.
88
,
(
9
)
4506
-
4507
.
Parkinson C, Whatmore AJ, Yates AP, Drake WM, Brabant G, Clayton PE, Trainer PJ
(
2003
)
.
The effect of pegvisomant-induced serum IGF-I normalization on serum leptin levels in patients with acromegaly
.
CLIN ENDOCRINOL
vol.
59
,
(
2
)
168
-
174
.
Drake WM, Carroll PV, Maher KT, Metcalfe KA, Camacho-Hübner C, Shaw NJ, Dunger DB, Cheetham TD et al.
(
2003
)
.
The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth
.
J Clin Endocrinol Metab
vol.
88
,
(
4
)
1658
-
1663
.
Drake WM, Hiorns MP, Kendler DL
(
2003
)
.
Hadju-Cheney syndrome: Response to therapy with bisphosphonates in two patients
.
J BONE MINER RES
vol.
18
,
(
1
)
131
-
133
.
Drake WM, Carroll PV, Savage MO, Monson JP
(
2002
)
.
Skeletal consequences of discontinuation of growth hormone at final height
.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
.
vol.
15
,
1351
-
1354
.
Parkinson C, Drake WM, Roberts ME, Meeran K, Besser GM, Trainer PJ
(
2002
)
.
A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin and pancreatic polypeptide responses to oral glucose and a standard mixed meal
.
J CLIN ENDOCR METAB
vol.
87
,
(
4
)
1797
-
1804
.
Newell-Price J, Morris DG, Drake WM, Korbonits M, Monson JP, Besser GM, Grossman AB
(
2002
)
.
Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome
.
J CLIN ENDOCR METAB
vol.
87
,
(
4
)
1640
-
1645
.
Parkinson C, Drake WM, Wieringa G, Yates AP, Besser GM, Trainer PJ
(
2002
)
.
Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegaly
.
CLIN ENDOCRINOL
vol.
56
,
(
3
)
303
-
311
.
Monson JP, Drake WM, Carroll PV, Weaver JU, Rodriquez-Arnao J, Savage MO
(
2002
)
.
Influence of growth hormone on accretion of bone mass
.
HORMONE RESEARCH
.
vol.
58
,
52
-
56
.
Drake WM, Brown JP, Banville C, Kendler DL
(
2002
)
.
Use of phalangeal bone mineral density and multi-site speed of sound conduction to monitor therapy with alendronate in postmenopausal women
.
OSTEOPOROSIS INT
vol.
13
,
(
3
)
249
-
256
.
Drake WM, Parkinson C, Besser GM, Trainer PJ
(
2001
)
.
Clinical use a of growth hormone receptor antagonist in the treatment of acromegaly
.
TRENDS ENDOCRIN MET
vol.
12
,
(
9
)
408
-
413
.
Frajese G, Drake WM, Loureiro RA, Evanson J, Coyte D, Wood DF, Grossman AB, Besser GM et al.
(
2001
)
.
Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy
.
J Clin Endocrinol Metab
vol.
86
,
(
11
)
5172
-
5175
.
Drake WM, Parkinson C, Akker SA, Monson JP, Besser GM, Trainer PJ
(
2001
)
.
Successful treatment of resistant acromegaly with a growth hormone receptor antagonist
.
EUR J ENDOCRINOL
vol.
145
,
(
4
)
451
-
456
.
Drake WM, Howell SJ, Monson JP, Shalet SM
(
2001
)
.
Optimizing gh therapy in adults and children
.
Endocr Rev
vol.
22
,
(
4
)
425
-
450
.
Trainer PJ, Drake WM, Perry LA, Taylor NF, Besser GM, Monson JP
(
2001
)
.
Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly
.
J CLIN ENDOCR METAB
vol.
86
,
(
7
)
2989
-
2992
.
Drake WM, Rodriguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM, Monson JP
(
2001
)
.
The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study
.
CLIN ENDOCRINOL
vol.
54
,
(
4
)
525
-
532
.
Drake WM, Lowe SR, Mirtella A, Bartlett TJ, Clark AJ
(
2000
)
.
Desensitisation of calcitonin gene-related peptide responsiveness but not adrenomedullin responsiveness in vascular smooth muscle cells
.
Journal of Endocrinology
vol.
165
,
(
1
)
133
-
138
.
Drake WM, Ajayi A, Lowe SR, Mirtella A, Bartlett TJ, Clark AJL
(
1999
)
.
Desensitization of CGRP and adrenomedullin receptors in SK-N-MC cells: implications for the RAMP hypothesis
.
Endocrinology
vol.
140
,
(
1
)
533
-
537
.
Drake WM, Perry LA, Hinds CJ, Lowe DG, Reznek RH, Besser GM
(
1998
)
.
Emergency and Prolonged Use of Intravenous Etomidate to Control Hypercortisolemia in a Patient with Cushing’s Syndrome and Peritonitis
.
The Journal of Clinical Endocrinology & Metabolism
vol.
83
,
(
10
)
3542
-
3544
.